![]() |
Volumn 39, Issue 10, 2017, Pages 2024-2037
|
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-olds
|
Author keywords
confounder in clinical research; failed clinical trial; incretin therapy; MK 3102; oral antihyperglycemic agent; patient nonadherence to the protocol
|
Indexed keywords
AMYLASE;
CREATINE KINASE;
GLUCOSE;
HEMOGLOBIN A1C;
METFORMIN;
OMARIGLIPTIN;
PLACEBO;
TRIACYLGLYCEROL LIPASE;
2-(2,5-DIFLUOROPHENYL)-5-(2-(METHYLSULFONYL)-2,6-DIHYDROPYRROLO(3,4-C)PYRAZOL-5(4H)-YL)TETRAHYDRO-2H-PYRAN-3-AMINE;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
FUSED HETEROCYCLIC RINGS;
GLYCOSYLATED HEMOGLOBIN;
PYRAN DERIVATIVE;
ADULT;
ARTICLE;
BODY MASS;
CONTROLLED STUDY;
DIARRHEA;
DISEASE DURATION;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSGEUSIA;
DYSPEPSIA;
FEMALE;
GASTROENTERITIS;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEADACHE;
HICCUP;
HUMAN;
HYPERTENSION;
HYPOGLYCEMIA;
INFLUENZA;
IRRITABLE COLON;
MAJOR CLINICAL STUDY;
MALE;
MEDICATION COMPLIANCE;
MONOTHERAPY;
MULTICENTER STUDY;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT COMPLIANCE;
PHARYNGITIS;
RANDOMIZED CONTROLLED TRIAL;
RHINITIS;
RHINOPHARYNGITIS;
SIDE EFFECT;
TREATMENT DURATION;
UPPER ABDOMINAL PAIN;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
ADOLESCENT;
ANALYSIS;
BLOOD;
COMBINATION DRUG THERAPY;
EPIDEMIOLOGY;
MIDDLE AGED;
YOUNG ADULT;
ADOLESCENT;
ADULT;
BLOOD GLUCOSE;
BODY MASS INDEX;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
GLYCATED HEMOGLOBIN A;
HETEROCYCLIC COMPOUNDS, 2-RING;
HUMANS;
MALE;
MEDICATION ADHERENCE;
METFORMIN;
MIDDLE AGED;
PYRANS;
YOUNG ADULT;
|
EID: 85029481797
PISSN: 01492918
EISSN: 1879114X
Source Type: Journal
DOI: 10.1016/j.clinthera.2017.08.009 Document Type: Article |
Times cited : (6)
|
References (11)
|